Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
(Adds details)LONDON, July 30 (Reuters) - The protection that vaccines give against coronavirus infection, and potentially severe disease, is highly likely to wane over time so vaccine campaigns will continue for years to come, scientists told the...
Read moreMOSCOW, July 30 (Reuters) - Trials mixing a first dose of the Russian-made Sputnik V vaccine with AstraZeneca's vaccine revealed no serious side effects among volunteers, the Russian Direct Investment Fund (RDIF) said on Friday.The trial involved ...
Read moreCAIRO - July 29 (Reuters) - Saudi Arabia's Tourism Ministry will re-allow entry for tourist visa holders starting Aug. 1, it said in a statement."Vaccinated tourists will be allowed to enter without having to be institutionally quarantined upon pr...
Read more
(Sharecast News) - AstraZeneca does not know yet whether so-called 'booster' shots of its Covid-19 vaccine will be needed or not.
Read more(Adds EU Commission spokesman, paragraph 4)LONDON, July 29 (Reuters) - AstraZeneca hopes to settle a legal dispute with the European Union over COVID-19 vaccine deliveries in the coming weeks, a senior executive said on Thursday, potentially endin...
Read more(Adds detail)By Francesco GuarascioLONDON, July 29 (Reuters) - AstraZeneca hopes to settle a legal dispute with the European Union over COVID-19 vaccine deliveries in the coming weeks, a senior executive said on Thursday, potentially ending a row ...
Read more(Adds detail, executive comments)LONDON, July 29 (Reuters) - AstraZeneca still plans to seek U.S. approval for its COVID-19 vaccine even though the process there is taking longer than expected, because it may still be used in the country in the fu...
Read more
TOP NEWS: AstraZeneca Covid jab sales top USD1 billion in first half
Read moreLONDON BRIEFING: Lloyds Banking to Embark on wealth management drive
Read more(Sharecast News) - AstraZeneca posted a jump in first-half revenue on Thursday as it updated its guidance to include recently-acquired Alexion Pharmaceuticals.
Read more* Sales of $1.17 bln in H1 from COVID-19 vaccine* Q2 earnings miss forecasts, sales beat* Now expects FY sales to grow by low-twenties percentage (Writes through with details)By Pushkala Aripaka and Alistair SmoutJuly 29 (Reuters) - Second-quarter s...
Read more* Sales of $1.17 bln in H1 from COVID-19 vaccine* Q2 earnings miss forecasts, sales beat* Now expects FY sales to grow by low-twenties percentage (Writes through with detail)By Pushkala Aripaka and Alistair SmoutJuly 29 (Reuters) - Second-quarter sa...
Read more(Adds detail)July 29 (Reuters) - AstraZeneca's COVID-19 vaccine sales more than tripled to $894 million in the second quarter from the previous three months, and the drugmaker updated its 2021 forecasts on Thursday to include sales from its Alexio...
Read moreJuly 29 (Reuters) - AstraZeneca's COVID-19 vaccine sales more than tripled to $894 million in the second quarter from the previous three months but shaved off 1 U.S. cent from earnings, and the drugmaker updated its 2021 forecasts on Thursday to ...
Read more* Sydney records 239 COVID-19 cases in 24 hours* 300 military personnel to aid police* Troops to aid enforcement of lockdown* Sydney lockdown threatens second recession (Adds details of Australian military personnel helping enforce lockdown of Sydn...
Read more
Last checked at